Phaxiam Therapeutics Sa Stock Ownership - Who owns Phaxiam Therapeutics Sa?

Insider buying vs selling

Have Phaxiam Therapeutics Sa insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PHXM insiders and whales buy or sell their stock.

PHXM Shareholders

What type of owners hold Phaxiam Therapeutics Sa stock?
Asset Dedication LLC0.01%400$1.88kInstitution
Ikarian Capital LLC0.01%301$1.41kInstitution
Ubs Group Ag0.00%7$32.90Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

PHXM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCLI9.78%72.95%Net Buying
VINC48.23%51.77%Net Buying
APRE1.46%98.54%Net Buying

Phaxiam Therapeutics Sa Stock Ownership FAQ

Who owns Phaxiam Therapeutics Sa?

Phaxiam Therapeutics Sa (NASDAQ: PHXM) is owned by 0.02% institutional shareholders, 0.00% Phaxiam Therapeutics Sa insiders, and 99.98% retail investors. Asset Dedication LLC is the largest individual Phaxiam Therapeutics Sa shareholder, owning 400.00 shares representing 0.01% of the company. Asset Dedication LLC's Phaxiam Therapeutics Sa shares are currently valued at $1.68k.

If you're new to stock investing, here's how to buy Phaxiam Therapeutics Sa stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.